EC Number   |
Source Tissue |
Reference |
|---|
   3.4.21.38 | blood |
- |
667868, 670943, 683726, 695504, 696927, 696931, 700443, 701242, 701287, 706942, 707649, 707839, 709320, 710605, 718010, 732404 |
| 3.4.21.38 | blood |
increased levels of activated coagulation factor XIIa are associated with coronary heart disease, sepsis, and diabetes |
653755 |
| 3.4.21.38 | blood |
venous blood samples |
683828 |
| 3.4.21.38 | blood plasma |
- |
691466, 701286, 709176, 731674, 732402, 753067, 753073, 753224, 753351, 95410, 95419 |
| 3.4.21.38 | blood plasma |
the high plasma titer of factor XII observed in estrogen-treated and prolactin-treated rats is caused by enhanced hepatic expression of both transcriptional and translational levels, as well as by increased secretion of factor XII |
95417 |
| 3.4.21.38 | commercial preparation |
highly purified coagulation beta-FXIIa |
707948 |
| 3.4.21.38 | epithelial ovarian cancer cell |
- |
708630 |
| 3.4.21.38 | ES-2 cell |
- |
708630 |
| 3.4.21.38 | fibroblast |
- |
709089 |
| 3.4.21.38 | hepatocyte |
cultured in serum-free medium |
95421 |
